Recombinant Human Erythropoietin in the Treatment of Human Brain Disease: Focus on Cognition

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 146-153

  Ehrenreich, Hannelore ^a   Bartels, Claudia ^a   Sargin, Derya ^a   Stawicki, Sabina ^a   Krampe, Henning ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANIMAL; ARTICLE; BRAIN; BRAIN DISEASE; COGNITION; DISEASE MODEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; MAMMAL; MENTAL DISEASE; PHYSIOLOGY; PRENATAL DEVELOPMENT; SPINAL CORD;

ANEMIA; ANIMALS; BRAIN; BRAIN DISEASES; COGNITION; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MAMMALS; MENTAL DISORDERS; SPINAL CORD;

RODENTIA;

EID: 37049035903     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.029     Document Type: Article

References (85)

1. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6 (2005) 484-494
2. Ehrenreich H. Medicine. A boost for translational neuroscience. Science 305 (2004) 184-185
3. Ehrenreich H., and Sirén A.L. Neuroprotection: what does it mean? What means do we have?. Eur Arch Psychiatry Clin Neurosci 251 (2001) 149-151
4. Hasselblatt M., Ehrenreich H., and Sirén A.L. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol 18 (2006) 132-138
5. Gassmann M., Heinicke K., Soliz J., et al. Non-erythroid functions of erythropoietin. Adv Exp Med Biol 543 (2003) 323-330
6. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev 72 (1992) 449-489
7. Jelkmann W. Effects of erythropoietin on brain function. Curr Pharm Biotechnol 6 (2005) 65-79
8. Juul S. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin Perinatol 31 (2004) 129-142
9. Sirén A.L., and Ehrenreich H. Erythropoietin: a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 251 (2001) 179-184
10. Ehrenreich H., Hasselblatt M., Knerlich F., et al. A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A 102 (2005) 862-867
11. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43 (1998) 40-49
12. Knabe W., Knerlich F., Washausen S., et al. Expression patterns of erythropoietin and its receptor in the developing midbrain. Anat Embryol (Berl) 207 (2004) 503-512
13. Shingo T., Sorokan S.T., Shimazaki T., and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21 (2001) 9733-9743
14. Knabe W., Sirén A.L., Ehrenreich H., and Kuhn H.J. Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) 210 (2005) 209-219
15. Ehrenreich H., Degner D., Meller J., et al. Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry 9 (2004) 42-54
16. Eid T., Brines M.L., Cerami A., et al. Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis. J Neuropathol Exp Neurol 63 (2004) 73-83
17. Sirén A.L., Knerlich F., Poser W., et al. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101 (2001) 271-276
18. Sakanaka M., Wen T.C., Matsuda S., et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A 95 (1998) 4635-4640
19. Bauer C., and Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol 51 (1989) 845-856
20. Chikuma M., Masuda S., Kobayashi T., et al. Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab 279 (2000) E1242-E1248
21. Sharp F.R., and Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5 (2004) 437-448
22. Beleslin-Cokic B.B., Cokic V.P., Yu X., et al. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 104 (2004) 2073-2080
23. Lewczuk P., Hasselblatt M., Kamrowski-Kruck H., et al. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 11 (2000) 3485-3488
24. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
25. Sirén A.L., Fratelli M., Brines M., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98 (2001) 4044-4049
26. Kilic E., Kilic U., Soliz J., et al. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. Faseb J 19 (2005) 2026-2028
27. Park M.H., Lee S.M., Lee J.W., et al. ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Biochem Biophys Res Commun 339 (2006) 1021-1028
28. Brines M., Grasso G., Fiordaliso F., et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A 101 (2004) 14907-14912
29. Livnah O., Stura E.A., Middleton S.A., et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283 (1999) 987-990
30. Jubinsky P.T., Krijanovski O.I., Nathan D.G., et al. The beta chain of the interleukin-3 receptor functionally associates with the erythropoietin receptor. Blood 90 (1997) 1867-1873
31. Tsai P.T., Ohab J.J., Kertesz N., et al. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci 26 (2006) 1269-1274
32. Leist M., Ghezzi P., Grasso G., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
33. Anagnostou A., Lee E.S., Kessimian N., et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A 87 (1990) 5978-5982
34. Morishita E., Masuda S., Nagao M., et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
35. Chattopadhyay A., Choudhury T.D., Bandyopadhyay D., and Datta A.G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol 59 (2000) 419-425
36. Kawakami M., Sekiguchi M., Sato K., et al. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J Biol Chem 276 (2001) 39469-39475
37. Kumral A., Genc S., Ozer E., et al. Erythropoietin downregulates Bax and DP5 proapoptotic gene expression in neonatal hypoxic-ischemic brain injury. Biol Neonate 89 (2005) 205-210
38. Liu J., Narasimhan P., Song Y.S., et al. EPO protects SOD2-deficient mouse astrocytes from damage by oxidative stress. Glia 53 (2006) 360-365
39. Bocker-Meffert S., Rosenstiel P., Rohl C., et al. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Invest Ophthalmol Vis Sci 43 (2002) 2021-2026
40. Konishi Y., Chui D.H., Hirose H., et al. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609 (1993) 29-35
41. Kertesz N., Wu J., Chen T.H., et al. The role of erythropoietin in regulating angiogenesis. Dev Biol 276 (2004) 101-110
42. Ribatti D., Presta M., Vacca A., et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93 (1999) 2627-2636
43. Wang L., Zhang Z., Wang Y., et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
44. Yu X., Shacka J.J., Eells J.B., et al. Erythropoietin receptor signalling is required for normal brain development. Development 129 (2002) 505-516
45. Bernaudin M., Marti H.H., Roussel S., et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19 (1999) 643-651
46. Brines M.L., Ghezzi P., Keenan S., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97 (2000) 10526-10531
47. Celik M., Gokmen N., Erbayraktar S., et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A 99 (2002) 2258-2263
48. Sadamoto Y., Igase K., Sakanaka M., et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253 (1998) 26-32
49. Villa P., Bigini P., Mennini T., et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198 (2003) 971-975
50. Grasso G., Buemi M., Alafaci C., et al. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99 (2002) 5627-5631
51. Springborg J.B., Ma X., Rochat P., et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 135 (2002) 823-829
52. Diem R., Sattler M.B., Merkler D., et al. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128 (2005) 375-385
53. Sattler M.B., Merkler D., Maier K., et al. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 11 suppl 2 (2004) S181-S192
54. Csete M., Rodriguez L., Wilcox M., and Chadalavada S. Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci Lett 359 (2004) 124-126
55. Genc S., Akhisaroglu M., Kuralay F., and Genc K. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett 321 (2002) 73-76
56. Genc S., Kuralay F., Genc K., et al. Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci Lett 298 (2001) 139-141
57. Grimm C., Wenzel A., Groszer M., et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8 (2002) 718-724
58. Bianchi R., Buyukakilli B., Brines M., et al. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A 101 (2004) 823-828
59. Campana W.M., and Myers R.R. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. Faseb J 15 (2001) 1804-1806
60. Keswani S.C., Buldanlioglu U., Fischer A., et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 56 (2004) 815-826
61. Erbayraktar S., de Lanerolle N., de Lotbiniere A., et al. Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med 12 (2006) 74-80
62. Chang K.H., Tam M., and Stevenson M.M. Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. J Infect Dis 189 (2004) 735-743
63. Kaiser K., Texier A., Ferrandiz J., et al. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis 193 (2006) 987-995
64. Gorio A., Gokmen N., Erbayraktar S., et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99 (2002) 9450-9455
65. Weishaupt J.H., Rohde G., Polking E., et al. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45 (2004) 1514-1522
66. Banks W.A., Jumbe N.L., Farrell C.L., et al. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol 505 (2004) 93-101
67. Martinez-Estrada O.M., Rodriguez-Millan E., Gonzalez-De Vicente E., et al. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18 (2003) 2538-2544
68. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16 (2004) 1-13
69. Ehrenreich H., Hasselblatt M., Dembowski C., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
70. Sirén A.L., Radyushkin K., Boretius S., et al. Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129 (2006) 480-489
71. Ehrenreich H., Hinze-Selch D., Stawicki S., et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry 12 (2007) 206-220
72. Ehrenreich H., Fischer B., Norra C., et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130 (2007) 2577-2588
73. Eschbach J.W., Egrie J.C., Downing M.R., et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316 (1987) 73-78
74. Kramer L., Madl C., Stockenhuber F., et al. Beneficial effect of renal transplantation on cognitive brain function. Kidney Int 49 (1996) 833-838
75. Pickett J.L., Theberge D.C., Brown W.S., et al. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 33 (1999) 1122-1130
76. Ehrenreich H., and Sirén A.-L. Benefits of recombinant human erythropoietin on cognitive function. Erythropoiesis: New dimensions in the treatment of anaemia 11 (2001) 35-40
77. Hengemihle J.M., Abugo O., Rifkind J., et al. Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice. Physiol Behav 59 (1996) 153-156
78. Weiskopf R.B., Feiner J., Hopf H., et al. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 104 (2006) 911-920
79. McArthur J.C., Hoover D.R., Bacellar H., et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43 (1993) 2245-2252
80. Beard C.M., Kokmen E., O'Brien P.C., et al. Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota. Ann Epidemiol 7 (1997) 219-224
81. Milward E.A., Grayson D.A., Creasey H., et al. Evidence for association of anaemia with vascular dementia. Neuroreport 10 (1999) 2377-2381
82. Kwack C., and Balakrishnan V.S. Managing erythropoietin hyporesponsiveness. Semin Dial 19 (2006) 146-151
83. Miskowiak K., O'Sullivan U., and Harmer C.J. Erythropoietin enhances hippocampal response during memory retrieval in humans. J Neurosci 27 (2007) 2788-2792
84. Randolph C. RBANS Manual-Repeatable Battery for the Assessment of Neuropsychological Status (1998), Psychological Corporation, Harcourt, TX
85. Kongs S.K., Thompson L.L., Iverson G.L., and Heaton R.K. WCST-64: Wisconsin Card Sorting Test-64 Card Version (2000), Psychological Assessment Resources, Odessa, FL